These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28667172)

  • 1. A haplotype variant of the human chromogranin A gene (
    Subramanian L; Khan AA; Allu PKR; Kiranmayi M; Sahu BS; Sharma S; Khullar M; Mullasari AS; Mahapatra NR
    J Biol Chem; 2017 Aug; 292(34):13970-13985. PubMed ID: 28667172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function.
    Lillie EO; Mahata M; Khandrika S; Rao F; Bundey RA; Wen G; Chen Y; Taupenot L; Smith DW; Mahata SK; Ziegler MG; Cockburn M; Schork NJ; O'Connor DT
    Circulation; 2007 May; 115(17):2282-91. PubMed ID: 17438153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.
    Rao F; Chiron S; Wei Z; Fung MM; Chen Y; Wen G; Khandrika S; Ziegler MG; Benyamin B; Montgomery G; Whitfield JB; Martin NG; Waalen J; Hamilton BA; Mahata SK; O'Connor DT
    Am J Hypertens; 2012 Jan; 25(1):29-40. PubMed ID: 21918574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.
    Chen Y; Rao F; Rodriguez-Flores JL; Mahapatra NR; Mahata M; Wen G; Salem RM; Shih PA; Das M; Schork NJ; Ziegler MG; Hamilton BA; Mahata SK; O'Connor DT
    Kidney Int; 2008 Jul; 74(1):115-25. PubMed ID: 18432188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.
    Friese RS; Altshuler AE; Zhang K; Miramontes-Gonzalez JP; Hightower CM; Jirout ML; Salem RM; Gayen JR; Mahapatra NR; Biswas N; Cale M; Vaingankar SM; Kim HS; Courel M; Taupenot L; Ziegler MG; Schork NJ; Pravenec M; Mahata SK; Schmid-Schönbein GW; O'Connor DT
    Hum Mol Genet; 2013 Sep; 22(18):3624-40. PubMed ID: 23674521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A polymorphisms are associated with hypertensive renal disease.
    Salem RM; Cadman PE; Chen Y; Rao F; Wen G; Hamilton BA; Rana BK; Smith DW; Stridsberg M; Ward HJ; Mahata M; Mahata SK; Bowden DW; Hicks PJ; Freedman BI; Schork NJ; O'Connor DT
    J Am Soc Nephrol; 2008 Mar; 19(3):600-14. PubMed ID: 18235090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.
    Chen Y; Rao F; Rodriguez-Flores JL; Mahata M; Fung MM; Stridsberg M; Vaingankar SM; Wen G; Salem RM; Das M; Cockburn MG; Schork NJ; Ziegler MG; Hamilton BA; Mahata SK; Taupenot L; O'Connor DT
    J Am Coll Cardiol; 2008 Oct; 52(18):1468-81. PubMed ID: 19017515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.
    Zhang K; Mir SA; Hightower CM; Miramontes-Gonzalez JP; Maihofer AX; Chen Y; Mahata SK; Nievergelt CM; Schork NJ; Freedman BI; Vaingankar SM; O'Connor DT
    J Am Soc Nephrol; 2015 Aug; 26(8):1816-25. PubMed ID: 25392232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis yields an unexpected trans-acting point in control of the human sympathochromaffin phenotype.
    Chiron S; Wei Z; Chen Y; Zhang K; Wen G; Fischer WH; Mahata SK; O'Connor DT
    Circ Cardiovasc Genet; 2011 Aug; 4(4):437-45. PubMed ID: 21551321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genetic variants of the catecholamine-release-inhibitory peptide catestatin in an Indian population: allele-specific effects on metabolic traits.
    Sahu BS; Obbineni JM; Sahu G; Allu PK; Subramanian L; Sonawane PJ; Singh PK; Sasi BK; Senapati S; Maji SK; Bera AK; Gomathi BS; Mullasari AS; Mahapatra NR
    J Biol Chem; 2012 Dec; 287(52):43840-52. PubMed ID: 23105094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.
    Chen Y; Rao F; Wen G; Gayen JR; Zhang K; Vaingankar SM; Biswas N; Mahata M; Friese RS; Fung MM; Salem RM; Nievergelt C; Bhatnagar V; Hook VY; Ziegler MG; Mahata SK; Hamilton BA; O'Connor DT
    Cell Mol Neurobiol; 2010 Nov; 30(8):1395-400. PubMed ID: 21061160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion.
    Greenwood TA; Rao F; Stridsberg M; Mahapatra NR; Mahata M; Lillie EO; Mahata SK; Taupenot L; Schork NJ; O'Connor DT
    Physiol Genomics; 2006 May; 25(3):470-9. PubMed ID: 16554546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation study on chromogranin A genetic polymorphism and prognosis of critically ill patients.
    Liu JL; Chen XY; Gu NN; Zhang JY; Jiang LP; Zhang D; Ren GS
    J Crit Care; 2017 Jun; 39():137-142. PubMed ID: 28254729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.
    Allu PKR; Kiranmayi M; Mukherjee SD; Chirasani VR; Garg R; Vishnuprabu D; Ravi S; Subramanian L; Sahu BS; Iyer DR; Maghajothi S; Sharma S; Ravi MS; Khullar M; Munirajan AK; Gayen JR; Senapati S; Mullasari AS; Mohan V; Radha V; Naga Prasad SV; Mahapatra NR
    Diabetes; 2022 Mar; 71(3):538-553. PubMed ID: 34862200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural variation within the neuronal nicotinic acetylcholine receptor cluster on human chromosome 15q24: influence on heritable autonomic traits in twin pairs.
    Rana BK; Wessel J; Mahboubi V; Rao F; Haeller J; Gayen JR; Eskin E; Valle AM; Das M; Mahata SK; Taupenot L; Stridsberg M; Talley TT; Ziegler MG; Smith DW; Schork NJ; O'Connor DT; Taylor P
    J Pharmacol Exp Ther; 2009 Nov; 331(2):419-28. PubMed ID: 19671882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.
    Zhang K; Rao F; Miramontes-Gonzalez JP; Hightower CM; Vaught B; Chen Y; Greenwood TA; Schork AJ; Wang L; Mahata M; Stridsberg M; Khandrika S; Biswas N; Fung MM; Waalen J; Middelberg RP; Heath AC; Montgomery GW; Martin NG; Whitfield JB; Baker DG; Schork NJ; Nievergelt CM; O'Connor DT
    J Am Coll Cardiol; 2012 Oct; 60(17):1678-89. PubMed ID: 23021333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A: a novel susceptibility gene for essential hypertension.
    Sahu BS; Sonawane PJ; Mahapatra NR
    Cell Mol Life Sci; 2010 Mar; 67(6):861-74. PubMed ID: 19943077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common Matrix metalloproteinase 8 promoter haplotype enhances the risk for hypertension via diminished interactions with nuclear factor kappa B.
    Maghajothi S; Subramanian L; Mani P; Singh M; Iyer DR; Sharma S; Khullar M; Victor SM; Asthana S; Mullasari AS; Mahapatra NR
    J Hypertens; 2022 Nov; 40(11):2147-2160. PubMed ID: 36040233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary function impairment in type 2 Diabetes patients associated with concentration and genetic polymorphisms of chromogranin A.
    Kogawa EM; Grisi DC; Falcão DP; Amorim IA; Rezende TM; da Silva IC; Silva ON; Franco OL; de Amorim RF
    Clin Oral Investig; 2016 Nov; 20(8):2083-2095. PubMed ID: 26750135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.
    Chen Y; Mahata M; Rao F; Khandrika S; Courel M; Fung MM; Zhang K; Stridsberg M; Ziegler MG; Hamilton BA; Lipkowitz MS; Taupenot L; Nievergelt C; Mahata SK; O'Connor DT
    J Am Soc Nephrol; 2009 Jul; 20(7):1623-32. PubMed ID: 19520754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.